Despite these various observations implicating BLT2 as a potential marker for aggressive metastatic cancer, the precise mechanism by which BLT2 promotes invasion and metastasis has not been definitively identified, especially in breast cancer cells. This evidence concerns the gene LTB4R2 and breast carcinoma.